<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <title>OpenSeadragon + SVG overlay</title>
    <link type="text/css" href="css/index.css" rel="stylesheet"/>
    <script src="https://d3js.org/d3.v4.min.js"></script>
    <script src="https://d3js.org/d3-selection-multi.v0.4.min.js"></script>

<!--    <link rel="stylesheet" href="//code.jquery.com/ui/1.11.4/themes/smoothness/jquery-ui.css">-->
<!--    <script src="//code.jquery.com/jquery-1.11.3.min.js"></script>-->
<!--    <script src="//code.jquery.com/ui/1.11.4/jquery-ui.min.js"></script>-->

</head>
<body>
<div id="openseadragon">
<!--    <div id="polygonAnnotationText">-->
<!--        <p>These are unpublished 13-plex t-CyCIF images of tissue specimens from four patients with BRAF-mutant metastatic melanoma resected before (left) and after (right) treatment with BRAF and MEK inhibitors (dabrafenib/trametinib). ”</p>-->
<!--    </div>-->

<!--    <div id="polygonAnnotationText2">-->
<!--        <p>Each image is composed of 150-200 image tiles at a resolution of ~0.9 μm. The Tumor Architecture markers represent tumor cells (S100), immune cells (CD45), and alpha smooth muscle actin in the stroma (α-SMA). Hoechst 33342 labels DNA in cell nuclei. These specimens were retrieved from the archives of the Brigham and Women’s Hospital under a discarded/excess tissue protocol detailed in Institutional Review Board (IRB) protocol IRB17-1688 (2018) for research deemed to “involve no more than minimal risk to the subjects.”</p>-->
<!--    </div>-->
</div>
<script src="js/openseadragon.js"></script>
<script src="js/openseadragon-svg-overlay.js"></script>
<script src="js/index.js"></script>
</body>
</html>